XML 46 R35.htm IDEA: XBRL DOCUMENT v3.26.1
1. Basis of Presentation and Use of Estimates Organization, Consolidation and Presentation of Financial Statements (Details) - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Dec. 31, 2025
Dec. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Line Items]        
Net sales $ 592.1 $ 585.4    
Cost of goods sold 282.7 279.4    
Deferred Revenue 69.9   $ 62.9  
Retained earnings 7,649.2   8,176.3  
Accumulated other comprehensive loss (235.4)   (189.1)  
Total stockholders' equity $ 6,851.3 6,679.4 7,453.6 $ 6,569.3
Revenue Allocation Percent To Lease Elements 3.00%      
Additional paid-in-capital $ 490.5   476.0  
Selling, general and administrative expense 212.4 208.8    
Research and Development Expense 62.9 73.5    
Interest expense 12.3 12.0    
Other Nonoperating Income (Expense) 24.2 37.2    
Deferred Revenue, Current 56.3   $ 48.9  
Europe [Member]        
Organization, Consolidation and Presentation of Financial Statements [Line Items]        
Net sales 206.8 199.8    
Asia Pacific [Member]        
Organization, Consolidation and Presentation of Financial Statements [Line Items]        
Net sales 110.4 104.1    
UNITED STATES        
Organization, Consolidation and Presentation of Financial Statements [Line Items]        
Net sales 229.8 241.7    
Americas [Member]        
Organization, Consolidation and Presentation of Financial Statements [Line Items]        
Net sales $ 45.1 $ 39.8